600998 九州通
已收盘 06-18 15:00:00
资讯
新帖
简况
每周股票复盘：九州通（600998）为32家子公司担保25.74亿元
证券之星 · 06-20 03:17
每周股票复盘：九州通（600998）为32家子公司担保25.74亿元
九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%
证券之星 · 06-16
九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%
九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%
证券之星 · 06-10
九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%
九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市
智通财经 · 06-02
九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市
九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%
证券之星 · 06-01
九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%
每周股票复盘：九州通（600998）子公司药品通过一致性评价
证券之星 · 05-31
每周股票复盘：九州通（600998）子公司药品通过一致性评价
九州通新提交“九州美学”、“未公开”等5件商标注册申请
证券之星 · 05-28
九州通新提交“九州美学”、“未公开”等5件商标注册申请
九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%
证券之星 · 05-26
九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%
九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价
智通财经 · 05-26
九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价
每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%
证券之星 · 05-24
每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%
九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%
证券之星 · 05-21
九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%
九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%
证券之星 · 05-20
九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%
九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%
证券之星 · 05-14
九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%
九州通(600998.SH)子公司通过药品GMP符合性检查
智通财经 · 05-06
九州通(600998.SH)子公司通过药品GMP符合性检查
每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%
证券之星 · 05-02
每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%
图解九州通年报：第四季度单季净利润同比下降65.56%
证券之星 · 04-28
图解九州通年报：第四季度单季净利润同比下降65.56%
每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理
证券之星 · 04-26
每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理
九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%
证券之星 · 04-21
九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%
每周股票复盘：九州通（600998）为56家子公司担保27.97亿元
证券之星 · 04-19
每周股票复盘：九州通（600998）为56家子公司担保27.97亿元
九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%
证券之星 · 04-15
九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%
加载更多
公司概况
公司名称：
九州通医药集团股份有限公司
所属行业：
批发业
上市日期：
2010-11-02
主营业务：
九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。
发行价格：
13.00
{"stockData":{"symbol":"600998","market":"SH","secType":"STK","nameCN":"九州通","latestPrice":4.83,"timestamp":1781766001000,"preClose":4.76,"halted":0,"volume":29599416,"delay":0,"changeRate":0.0147,"floatShares":5042000000,"shares":5042000000,"eps":0.4003,"marketStatus":"已收盘","change":0.07,"latestTime":"06-18 15:00:00","open":4.76,"high":4.86,"low":4.68,"amount":142000000,"amplitude":0.0378,"askPrice":4.84,"askSize":1606,"bidPrice":4.83,"bidSize":1162,"shortable":0,"etf":0,"ttmEps":0.4003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.76,"symbolType":"stock","openAndCloseTimeList":[[1781746200000,1781753400000],[1781758800000,1781766000000]],"highLimit":5.24,"lowLimit":4.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":5042470234,"isCdr":false,"pbRate":0.89,"roa":"--","peRate":12.065951,"roe":"2.62%","epsLYR":0.44,"committee":-0.699608,"marketValue":24355000000,"turnoverRate":0.0059,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-06-22。","floatMarketCap":24355000000},"requestUrl":"/m/hq/s/600998","defaultTab":"news","newsList":[{"id":"2644065063","title":"每周股票复盘：九州通（600998）为32家子公司担保25.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065063?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:17","pubTimestamp":1781896630,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，九州通报收于4.83元，较上周的4.79元上涨0.84%。本周，九州通6月15日盘中最高价报4.88元。本周关注点公司公告汇总：九州通为32家子公司提供合计257,400.00万元担保。截至2026年5月31日，公司对外担保总额为3,137,318.72万元，占最近一期经审计净资产的109.87%，无逾期担保。担保对象主要为控股子公司及其下属企业，公司拥有控制权，经营状况良好，担保风险可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0012","BK0183","BK0201","BK0250","BK0196","BK0146","BK0187","BK0188","BK0039","600998","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643557737","title":"九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643557737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643557737?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:23","pubTimestamp":1781605384,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，九州通报收于4.79元，较前一交易日下跌1.64%，最新总市值为241.53亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。截至2026年5月31日，公司对外担保总额为3,137,318.72万元，占最近一期经审计净资产的109.87%，无逾期担保。担保对象主要为控股子公司及其下属企业，公司拥有控制权，经营状况良好，担保风险可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0196","BK0146","BK0183","600998","BK0028","BK0077","BK0097","BK0187","BK0012","BK0039","BK0188","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428892","title":"九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428892","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428892?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:43","pubTimestamp":1781088215,"startTime":"0","endTime":"0","summary":"证券之星消息，九州通6月10日公开信息显示，股东楚昌投资集团有限公司向平安银行股份有限公司武汉分行合计质押8500.0万股，占总股本1.69%。本文数据来源于九州通公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000035343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0201","BK0188","BK0077","BK0183","BK0187","BK0012","BK0196","600998","BK0028","BK0250","BK0039","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986916","title":"九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986916","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640986916?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:53","pubTimestamp":1780390421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，公司控股子公司北京京丰制药(山东)有限公司于2026年6月1日收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》，批准盐酸氮䓬斯汀上市申请。据悉，盐酸氮䓬斯汀是一种选择性组胺H1受体拮抗剂，具有抗组胺及抗过敏作用，可阻止过敏反应中某些化学介质(如白三烯、组胺)的合成和释放，并能够抑制嗜酸性粒细胞的移行，发挥广泛抗炎作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0196","BK0146","IPOS","BK0183","600998","BK0028","BK0077","BK0097","BK0187","BK0012","BK0039","BK0188","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640167950","title":"九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640167950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640167950?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:29","pubTimestamp":1780324158,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，九州通报收于4.9元，较前一交易日上涨2.08%，最新总市值为247.08亿元。公司拟以2025年度权益分派股权登记日总股本扣除回购专户股份为基数，向全体普通股股东每10股派发现金红利2.00元（含税），不进行资本公积转增股本。截至2026年5月20日，公司总股本为5,042,470,234股，回购专户持有56,036,500股，实际参与分配股份数为4,986,433,734股，合计派发现金红利997,286,746.80元。本次差异化权益分派对除权除息参考价格影响小于1%，符合相关监管规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","600998","BK0039","BK0187","BK0196","BK0012","BK0183","BK0201","BK0028","BK0097","BK0077","BK0250","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604709","title":"每周股票复盘：九州通（600998）子公司药品通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604709?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:17","pubTimestamp":1780172229,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，九州通报收于4.8元，较上周的4.79元上涨0.21%。本周关注点公司公告汇总：子公司盐酸苯海索片通过仿制药一致性评价公司公告汇总：该药品2025年医院销售额为0.86亿元公司公告汇总：山东京丰已投入研发费用约685万元公司公告汇总九州通子公司北京京丰制药（山东）有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准该药品通过仿制药质量和疗效一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0039","BK0183","BK0097","BK0196","BK0187","BK0146","BK0012","600998","BK0250","BK0188","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634152","title":"九州通新提交“九州美学”、“未公开”等5件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638634152?lang=zh_cn&edition=full","pubTime":"2026-05-28 06:41","pubTimestamp":1779921687,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日九州通医药集团股份有限公司新提交“九州美学”、“未公开”等5件商标注册申请。商标申请详情如下：今年以来九州通医药集团股份有限公司新申请注册商标22件，截止目前公司共持有注册商标1244件，另有199件商标尚在注册申请中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800005323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0146","BK0188","BK0196","BK0250","BK0183","BK0012","BK0077","BK0028","BK0187","600998","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543757","title":"九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543757?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:45","pubTimestamp":1779806720,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，九州通报收于4.82元，较前一交易日上涨0.63%，最新总市值为243.05亿元。近日，九州通发布关于子公司药品通过仿制药一致性评价的公告。公告显示，九州通子公司北京京丰制药（山东）有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准该药品通过仿制药质量和疗效一致性评价。盐酸苯海索片为国家医保甲类品种，用于治疗帕金森病及药物引起的锥体外系反应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0201","BK0028","BK0187","BK0250","BK0077","BK0039","BK0097","BK0196","BK0012","BK0183","BK0146","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638590901","title":"九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2638590901","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638590901?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:23","pubTimestamp":1779787410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，近日，公司子公司北京京丰制药(山东)有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准盐酸苯海索片(2mg)通过仿制药质量和疗效一致性评价(简称“一致性评价”)。据悉，盐酸苯海索片是一种抗胆碱能药物，该药可选择性阻断纹状体的胆碱能神经通路，而对外周作用较小，从而有利于恢复帕金森病患者脑内多巴胺和乙酰胆碱的平衡，改善患者的帕金森病症状;对于抗精神病药等药物引发的锥体外系反应，本品也有良好疗效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0201","BK0039","BK0250","BK0183","600998","BK0077","BK0146","BK0188","BK0196","BK0187","BK0028","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637730773","title":"每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637730773","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637730773?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:10","pubTimestamp":1779563422,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，九州通报收于4.79元，较上周的4.95元下跌3.23%。本周，九州通5月18日盘中最高价报4.94元。截至2026年4月30日，公司对外担保总额为2,986,518.62万元，占最近一期经审计净资产的104.59%，其中对资产负债率超过70%的子公司提供担保152,550.00万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600998","BK0097","BK0146","BK0196","BK0187","BK0077","BK0201","BK0039","BK0188","BK0028","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375563","title":"九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375563","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375563?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:51","pubTimestamp":1779375072,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，九州通报收于4.81元，较前一交易日下跌1.43%，最新总市值为242.54亿元。近日，九州通医药集团股份有限公司披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月21日召开2025年年度股东会，审议通过了2025年度董事会工作报告、年度报告及摘要、独立董事述职报告、利润分配预案、董事薪酬议案、续聘中审众环会计师事务所为2026年审计机构、修订部分管理制度等议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0201","BK0077","BK0039","BK0250","BK0028","BK0097","BK0146","600998","BK0012","BK0187","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636725845","title":"九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636725845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636725845?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:30","pubTimestamp":1779273038,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，九州通报收于4.88元，较前一交易日下跌0.81%，最新总市值为246.07亿元。九州通于2026年5月20日发布《关于为子公司提供担保的进展公告》。公告显示，公司为河南九州通医药有限公司、山东九州通医药有限公司等49家子公司提供合计292,050.00万元的担保，均为前期预计额度内的担保，且部分担保设有反担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0146","BK0012","BK0196","BK0028","BK0187","600998","BK0201","BK0250","BK0039","BK0183","BK0077","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635274745","title":"九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635274745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635274745?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:31","pubTimestamp":1778769073,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，九州通报收于4.99元，较前一交易日下跌1.58%，最新总市值为251.62亿元。该股当日开盘5.06元，最高5.07元，最低4.97元，成交额达1.69亿元，换手率为0.67%。近日，九州通医药集团股份有限公司披露《2025年年度股东会会议资料》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0201","BK0250","600998","BK0187","BK0183","BK0012","BK0097","BK0146","BK0196","BK0028","BK0039","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633584188","title":"九州通(600998.SH)子公司通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2633584188","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633584188?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:02","pubTimestamp":1778058136,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，近日，公司子公司北京京丰制药(山东)有限公司(简称“山东京丰”)收到山东省药品监督管理局核准签发的《药品GMP符合性检查告知书》(编号：GMP2026081)。公司积极拓展医药工业自产及OEM业务，持续强化药品研发及生产能力，打造具有核心竞争力的产品矩阵，2025年医药工业自产及OEM业务实现销售收入33.33亿元，同比增长10.81%。山东京丰本次片剂生产线顺利通过GMP现场符合性检查，表明公司产品生产质量管理符合药品GMP要求，有利于公司继续保持稳定的产品质量和持续稳定的生产能力，以满足相关药品的市场需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","BK0097","BK0201","BK0039","BK0012","BK0077","BK0146","BK0196","BK0188","BK0187","BK0250","BK0028","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632444326","title":"每周股票复盘：九州通（600998）股东户数增13.92%，净利降24.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632444326","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632444326?lang=zh_cn&edition=full","pubTime":"2026-05-02 03:20","pubTimestamp":1777663222,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，九州通报收于5.17元，较上周的5.41元下跌4.44%。本周关注点股本股东变化：股东户数较上年末增加13.92%，达5.84万户业绩披露要点：归母净利润7.33亿元，同比下降24.41%股本股东变化股东户数变动截至2026年3月31日，九州通股东户数为5.84万户，较2025年12月31日增加7135户，增幅13.92%。业绩披露要点财务报告2026年一季度，九州通实现主营收入447.83亿元，同比增长6.58%；归母净利润7.33亿元，同比下降24.41%；扣非净利润5.43亿元，同比增长7.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0012","BK0188","BK0187","BK0146","BK0183","BK0028","BK0250","BK0201","BK0077","600998","BK0097","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630316094","title":"图解九州通年报：第四季度单季净利润同比下降65.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630316094","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630316094?lang=zh_cn&edition=full","pubTime":"2026-04-28 00:54","pubTimestamp":1777308873,"startTime":"0","endTime":"0","summary":"证券之星消息，九州通2025年年报显示，当年度公司主营收入1613.9亿元，同比上升6.31%；归母净利润22.55亿元，同比下降10.07%；扣非净利润17.48亿元，同比下降3.63%；其中2025年第四季度，公司单季度主营收入420.63亿元，同比上升9.6%；单季度归母净利润2.79亿元，同比下降65.56%；单季度扣非净利润2.78亿元，同比上升50.99%；负债率68.33%，投资收益10.0亿元，财务费用9.42亿元，毛利率7.78%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800002515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630017428","title":"每周股票复盘：九州通（600998）子公司药品上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2630017428","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630017428?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:00","pubTimestamp":1777143634,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，九州通报收于5.41元，较上周的5.26元上涨2.85%。本周，九州通4月24日盘中最高价报5.48元。本周关注点公司公告汇总：控股子公司盐酸氮斯汀鼻喷雾剂上市申请获国家药监局受理。本次申请事项为境内生产药品注册上市许可，受理号为CYHS2600898。该药品注册申请已获受理，后续还需经过审评、审批等环节，存在不确定性，短期内不会对公司经营业绩产生影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","BK0097","BK0187","BK0039","BK0196","BK0183","BK0012","BK0250","600998","BK0201","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030058","title":"九州通（600998）披露子公司盐酸氮䓬斯汀鼻喷雾剂上市申请获国家药监局受理，4月21日股价上涨1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030058","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629030058?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:30","pubTimestamp":1776781816,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，九州通报收于5.38元，较前一交易日上涨1.32%，最新总市值为271.28亿元。该股当日开盘5.3元，最高5.39元，最低5.29元，成交额达1.95亿元，换手率为0.72%。近日，九州通医药集团股份有限公司控股子公司北京京丰制药集团有限公司收到国家药品监督管理局签发的盐酸氮斯汀鼻喷雾剂上市申请《受理通知书》。本次申请事项为境内生产药品注册上市许可，受理号为CYHS2600898。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100053652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0146","BK0012","BK0196","BK0028","BK0187","600998","BK0201","BK0250","BK0039","BK0183","BK0077","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628807759","title":"每周股票复盘：九州通（600998）为56家子公司担保27.97亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628807759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628807759?lang=zh_cn&edition=full","pubTime":"2026-04-19 02:19","pubTimestamp":1776536346,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，九州通报收于5.26元，较上周的5.36元下跌1.87%。本周，九州通4月15日盘中最高价报5.43元。九州通当前最新总市值265.23亿元，在医药商业板块市值排名3/32，在两市A股市值排名824/5198。本周关注点公司公告汇总：九州通为56家子公司提供合计279,670.00万元担保。公司公告汇总：截至2026年3月31日，公司对外担保总额达3,057,968.62万元。公司董事会认为担保风险可控，符合子公司经营需要。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0039","BK0183","BK0097","BK0196","BK0187","BK0146","BK0012","600998","BK0250","BK0188","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627223870","title":"九州通（600998）披露为子公司提供担保的进展公告，4月15日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627223870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627223870?lang=zh_cn&edition=full","pubTime":"2026-04-15 22:22","pubTimestamp":1776262973,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，九州通报收于5.4元，较前一交易日上涨1.69%，最新总市值为272.29亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。公告显示，公司为河南九州通医药有限公司、江苏九州通医药有限公司等56家子公司提供合计279,670.00万元的担保，均为对控股子公司及其下属企业的担保。截至2026年3月31日，公司对外担保总额为3,057,968.62万元，占最近一期经审计净资产的112.25%，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500043184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0146","BK0012","BK0183","BK0028","BK0196","BK0188","BK0250","BK0039","600998","BK0187","BK0201","BK0097"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781984525580,"stockEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0224},{"period":"3month","weight":-0.0215},{"period":"6month","weight":-0.029},{"period":"1year","weight":-0.0157},{"period":"ytd","weight":-0.0175}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.0337},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2071},{"period":"ytd","weight":0.0306}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"九州通医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"58392人(较上一季度增加13.92%)","perCapita":"86355股","listingDate":"2010-11-02","address":"湖北省武汉市汉阳区龙兴西街5号","registeredCapital":"504247万元","survey":" 九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九州通,600998,九州通股票,九州通股票老虎,九州通股票老虎国际,九州通行情,九州通股票行情,九州通股价,九州通股市,九州通股票价格,九州通股票交易,九州通股票购买,九州通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}